Autologous dendritic cell vaccine for estrogen receptor (ER)/progestin receptor (PR) double-negative breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2012-09-01 / Cancer Immunol Immunother 2012 Sep;61(9):1415-24Immunotherapy in ovarian cancer
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2012-08-21 / Hum Vaccin Immunother 2012 Sep;8(9):1179-91NK cells: key to success of DC-based cancer vaccines?
/in Dendritic Cells, International Publications /von 2012-08-20 / Oncologist 2012;17(10):1256-70Morphologic evidence of anti-tumor specificity of T cells activated by denritic cells derived from peripheral blood mononuclear cells of thyroid cancer patients
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2012-08-10 / Korean J. Physiol. Pharmacol. 2012 Aug;16(4):243-7Dendritic cell vaccine modified by Ag85A gene enhances anti-tumor immunity against bladder cancer
/in Dendritic Cells, International Publications, Urothelial Carcinoma /von 2012-08-09 / Int. Immunopharmacol. 2012 Nov;14(3):252-60Dendritic cell-based vaccination in metastatic melanoma patients: phase II clinical trial
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2012-08-07 / Oncol. Rep. 2012 Oct;28(4):1131-8Dendritic cell engineering for tumor immunotherapy: from biology to clinical translation
/in Dendritic Cells, International Publications /von 2012-07-01 / Immunotherapy 2012 Jul;4(7):703-18Immunotherapies for non-small-cell lung cancer and mesothelioma
/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2012-06-28 / Lancet Oncol. 2012 Jul;13(7):e301-10Phase I immunotherapy trial using glioblastoma apoptotic body-pulsed dendritic cells.
/in Dendritic Cells, Glioblastoma, International Publications /von 2012-06-04 / J Clin Oncol 30, 2012 (suppl; abstr 2546)IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de